FindTrial
Sign In

CRE Active Screening And Effect Evaluation

CRE Active Screening And Effect Evaluation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000028907
Enrollment
Unknown
Registered
2020-01-07
Start date
2018-02-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

All patients admitted to the ICU

Interventions

Case series:Nil

Sponsors

Liaoning Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All ICU patients admitted in the past year

Exclusion criteria

Exclusion criteria: Postoperative observation of patients

Design outcomes

Primary

MeasureTime frame
CRE carrying rate and homology of admitted patients;The CRE carrying rate and homology of the patients;The CRE carrying rate and homology of the patients;The CRE carrying rate and homology of the patients;Analysis of CRE infection and mortality in patients with positive CRE anal swab;—

Secondary

MeasureTime frame
Effect of carbapenem/quinolone/third generation cefore on CRE infection rate and carrying rate;—

Contacts

Public ContactFeng Xinghuo

Liaoning Provincial People's Hospital

wh640219@163.com+86 17702487766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026